Defence Therapeutics appoints ex-Xenon CFO Sherry Aulin to board, audit committee

• Defence Therapeutics appointed finance executive Sherry Aulin to its board, adding her to the audit committee.
• Aulin was most recently CFO of Xenon Pharmaceuticals, serving for over a decade.
• She helped lead Xenon’s Nasdaq IPO, shaping corporate strategy, raising more than USD 1 billion in equity capital.
• Earlier roles included senior positions at KPMG, advising public companies including life sciences.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Defence Therapeutics Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609290315NEWSFILECNPR____20260929_316430_1) on September 29, 2026, and is solely responsible for the information contained therein.